Jenoptik Ag · XETR:JEN

Jenoptik — Investor Presentation (May 2026)

52 slides from Jenoptik's investor presentation, May 2026

  1. Slide 1: Our Vision – Brighter Futures with the Power of Light

    Our Vision – Brighter Futures with the Power of Light. Investor Relations Presentation I May/June 2026 © Copyright Jenoptik. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the

  3. Slide 3: Agenda

    Agenda Company overview Divisional set-up Results Q1/2026 and outlook Appendix Jenoptik Investor Relations Presentation 3

  4. Slide 4: Jenoptik at a glance – a leading globally operating photonics group

    Jenoptik at a glance – a leading globally operating photonics group 1991 Year of foundation Our Mission >80 Represented in countries The Leading Light In the Application of ~4,500 Employees worldwide Photonics ~2.05bn1 Market capitalization in euros Fiscal year 2025 Focus on four growth areas ~1.05

  5. Slide 5: Addressing multiple mega-trends with our strong photonics expertise

    Addressing multiple mega-trends with our strong photonics expertise We enable the digital age We ensure superb quality in demanding production processes We enable the digital age We drive life science We make roads and cities and healthcare development safer Jenoptik Investor Relations Presentation

  6. Slide 6: Clear focus on attractive markets

    Clear focus on attractive markets Semiconductor & Advanced Metrology & Production Manufacturing Solutions Optics, Micro-optics Precision components 42% 20% OEM businesses OEM generate Solutions businesses ~2/3 of revenue businesses Biophotonics Smart Mobility Solutions 12% 23% 3% Based on FY 2025 da

  7. Slide 7: Strong value proposition: Leading photonics expertise combined with strong customer relationships

    Strong value proposition: Leading photonics expertise combined with strong customer relationships Customer access / relationship Technology Industrial Joint R&D Shared R&D Designed-in Application Manufacturing manufacturing programmes roadmaps solutions excellence capacity know how Evolution Supplie

  8. Slide 8: Portfolio aligned to future markets of photonics; focus on organic growth

    Portfolio has been aligned to future markets of photonics; focus on organic growth Priorities Initiatives − Increased customer focus Organic growth − Investment in new application areas and regions Utilization − Reorganization Operational excellence of photonic ▪ Allocation of production units growt

  9. Slide 9: Streamlined organizational structure to enhance customer focus and efficiency

    Streamlined organizational structure implemented to enhance customer focus and efficiency Jenoptik has become more simple − Matrix structure largely removed in 2024 Stronger customer focus, more − Full allocation of plants to individual efficiency clearer responsibilities Strategic Business Units Se

  10. Slide 10: Robust track record of profitable growth

    Robust track record of profitable growth 2014 – 2025 Main driver to margin expansion Revenue CAGR >5% − Product mix effects EBITDA margin increased >5 percentage points − Operating leverage 1200 1150 21-22% 21,0% 1100 1050 19.9% 1000 18.4% 950 19.7% 19,0% 900 850 18.8%1 800 17,0% 750 ~590 1 700 mill

  11. Slide 11: Substantial investments to support organic growth

    Substantial investments to support organic growth Significant investments into production capacities New Semi Fab in Dresden − Doubling production with new micro-optics cleanroom fab (LEED certified) in Dresden; production started in early 2025 − New biophotonics production site in Berlin inaugurate

  12. Slide 12: Robust key financial figures; net debt reflects recent acquisitions

    Robust key financial figures; net debt reflects recent acquisitions Key financial ratios Net debt and net debt to EBITDA 1 Acquisition 4,0 700 Jenoptik Group Q1/2026 FY 2025 BG Medical/ 3,5 600 SwissOptic (end 2021) 3,0 Equity ratio in % 60.4 60.2 500 1.6x 2,5 400 2,0 Net debt in 313.0 317.4 300 mil

  13. Slide 13: Capital allocation priorities focus on organic growth

    Capital allocation priorities in current strategy period focus on organic growth Capital allocation New capital allocation priorities 2018 – 2024 ~10% 1 Investment into organic growth (Capex, R&D) ~1.2bn euros of 2 ~35% ~55% capital allocated Return to shareholders 2018 – 2025 M&A CAPEX Dividends 3

  14. Slide 14: New sustainability targets 2030

    New sustainability targets 2030 ESG-Area KPI 2025 Target 2025 Target 2030 Partnership Jenoptik‘s for the goals sustainability ratings Share of green 96.8% >90% 100% electricity Environment CO2 reduction 59.0% >55% 70% Diversity rate 31.0% 33% 33% 09/2025 AA Rating - Top 17 percent ranked in global E

  15. Slide 15: Divisional set-up

    Divisional set-up

  16. Slide 16: Leaner organizational structure to increase customer focus and efficiency

    Leaner organizational structure to increase customer focus and efficiency and more clearly assign responsibilities Semiconductor & Metrology & Smart Mobility Advanced Biophotonicss Production Solutions Manufacturing Solutions − Optical and micro- − Optical components for − Systems and service for −

  17. Slide 17: Semiconductor & Advanced Manufacturing

    Jenoptik is strongly rooted in main applications IC lithography and IC inspection Markets Semiconductor & Advanced Manufacturing − Supplier to global manufacturers of wafer fab equipment for optical lithography and inspection Main − Performance-critical, designed-in optical and micro-optical modules

  18. Slide 18: Semiconductor market expectations remain robust

    Semiconductor market expectations remain robust; Multiple drivers support mid-term equipment market growth Wafer Fab Equipment Market1 Main chip demand drivers: (billion USD) Digitalization (AI & cloud infrastructure, 5G connectivity, edge computing) Climate change & resource scarcity 180 (Electrifi

  19. Slide 19: Chip manufacturing: photonics plays a critical role along the process

    Chip manufacturing: photonics plays a critical role along the process Front-end Back-end Main photonics applications Wafer level Diffusion Deposition Lithography Etching Implant CMP Packaging packaging e.g. advanced / 3D- e.g. co-packaged packaging optics Inspection/Metrology Inspection/Metrology Us

  20. Slide 20: Strong position in the global semi supply chain; revenues more than doubled since 2020

    Jenoptik leverages its strong position in the global semi supply chain; revenues more than doubled since 2020 – CAGR (organic) >10% Key business features: Main demand drivers: ▪ Chip fabrication capacity expansion Close customer relationships with leading OEM‘s ▪ New technologies both front and back

  21. Slide 21: New state-of-the-art fab in Dresden opened on time in Q1 2025

    New state-of-the-art fab in Dresden opened on time in Q1 2025 − Largest single investment in recent history (just under 100m euros) − Expanding production & research and development capacities for innovative micro-optics − Extremely demanding manufacturing environment (clean rooms meet the highest r

  22. Slide 22: Biophotonics

    Developing new applications in the area of Medtech & Life Sciences Markets Biophotonics − Supplier to global Medtech & Life Science OEM manufacturers Main − Performance-critical, designed-in modules and sub-systems characteristics − Key account approach / strong relationship to market leading custom

  23. Slide 23: Biophotonics: main Medtech and Life Sciences applications and drivers

    Biophotonics: main Medtech and Life Sciences applications and drivers Our products portfolio enables diagnostics and therapy, e.g. − imaging solutions for dentistry and (robotic) surgery − disk lasers for ophthalmology − readheads for DNA sequencing and fluorescence microscopy − illumination and cam

  24. Slide 24: Biophotonics: optical defense portfolio & position

    Biophotonics: optical defense portfolio & position Well established supplier of high-end optical defense products Our product portfolio supports defense and industrial applications by leveraging technological synergies, e.g. ‒ Laser rangefinders ‒ Thermal imaging (IR) cameras ‒ Light Emitting Diodes

  25. Slide 25: Metrology & Production Solutions

    Addressing highly specialized application with a broad portfolio for efficient quality control and production solutions Markets Metrology & Production Solutions − Supplier of high-end testing and production solutions incl. service Main − Main end-markets include automotive and electronics, as well a

  26. Slide 26: Deploying strong technology basis to realize growth in new/emerging fields

    Deploying strong technology basis to realize growth opportunities in new/emerging fields ELECTRONICS manufacturing OPTICS manufacturing AUTOMOTIVE manufacturing adjacent applications Quality Inspection Visionline Opticline Mechanical Shaft parts testing measurement ImageMaster OptiCentric OptiSurf P

  27. Slide 27: Smart Mobility Solutions

    Addressing highly specialized application with a broad portfolio of quality control and production solutions Markets Smart Mobility Solutions − Provider of solutions for traffic law enforcement, civil security and road user charging Main − Offers equipment and software, including integration, instal

  28. Slide 28: Smart Mobility Solutions Division: main demand drivers and applications

    Smart Mobility Solutions Division: main demand drivers and applications Traffic Law Enforcement Civil Security Road User Charging − New applications such as distracted driving − Growing demand for integrated services − Political initiatives such as Vision Zero in additional countries − Overall avera

  29. Slide 29: Results first quarter 2026

    Results first quarter 2026

  30. Slide 30: OEM businesses drive significant increase in order intake

    OEM businesses drive significant increase in order intake Business development: Semiconductor & Advanced Manufacturing − Substantially higher demand in OEM business, in particular in the semiconductor equipment industry − Revenue slightly down on prior year, as expected − EBITDA margin significantly

  31. Slide 31: Highest quarterly order intake in years

    Highest quarterly order intake in years supported by single major order, amongst other things Order intake in MEUR 400 74.4% 356.9 300 In million euros Q1/2026 Q1/2025 Change in % Semiconductor & Advanced Manufacturing 180.2 68.6 162.7 200 Biophotonics 73.9 44.7 65.5 204.6 Metrology & Production Sol

  32. Slide 32: Q1/2026: revenue still slightly below prior year

    Q1/2026: revenue still slightly below prior year Revenue in MEUR 300 − 1.0% 243.6 241.2 In million euros Q1/2026 Q1/2025 Change in % 200 Semiconductor & Advanced Manufacturing 108.2 100.9 7.2 Biophotonics 56.8 63.8 –10.9 100 Metrology & Production Solutions 39.1 40.6 –3.7 Smart Mobility Solutions 31

  33. Slide 33: EBITDA margin increased to 18.4% compared to 14.9%

    EBITDA margin increased to 18.4% compared to modest prior-year level of 14.9% EBITDA in MEUR 50 22.5% EBITDA in million euros EBITDA in % 40 44.4 Q1/2026 Q1/2025 Q1/2026 Q1/2025 30 36.2 Semiconductor & Advanced Manufacturing 33.7 21.4 30.6 20.5 20 Biophotonics 12.5 15.6 21.9 24.4 Metrology & Product

  34. Slide 34: Earnings figures clearly above modest prior-year level

    Earnings figures clearly above modest prior-year level In million euros Q1/2026 Q1/2025 Change in % Revenue 241.2 243.6 −1.0 − Gross margin influenced in particular by higher contribution of Semiconductor & Advanced Gross margin 35.4% 30.9% Manufacturing Functional costs − Functional cost ratio amou

  35. Slide 35: Free cash flow impacted by working capital; financial position very strong

    Free cash flow impacted by increase in working capital; financial position remains very strong In million euros Q1/2026 Q1/2025 Change in % Cash flows from operating − Cash flows from operating activities impacted by 28.7 54.9 −47.7 activities before income taxes increase (prior year: reduction) in

  36. Slide 36: Revenue and margin guidance for 2026 confirmed

    Revenue and margin guidance for 2026 confirmed Semiconductor & Advanced Manufacturing Targets 2026 − Revenue increase in single-digit percentage range (2025: 1,046.0 million euros) Biophotonics − EBITDA margin between 19.0 and 21.0 percent (2025: 18.4%) − Investments slightly below prior year (2025:

  37. Slide 37: Appendix

    Appendix

  38. Slide 38: Innovation remains our main growth engine

    Innovation remains our main growth engine through our leading competencies in… − Harnessing light − Helping our customers to solve highly complex photonic problems − Design and industrialization of complex optics ©NASA/JPL-Caltech and photonics components − Decoding photonic signals in data imaging

  39. Slide 39: Megatrends will drive growing demand for photonics solutions

    Megatrends will drive growing demand for photonics solutions of the future Societal needs Jenoptik‘s contribution Growing demand for chips for various existing Jenoptik supplies high-performance optics, Digitization as well as new applications; increasing usage of micro-optics for semiconductor equi

  40. Slide 40: A long tradition of innovation in optoelectronics

    A long tradition of innovation in optoelectronics Vollbild anzeigen 19 20 21 22 23 1846 1946 1989-91 1992-98 1998-2006 2007-16 since 2017 Founded State German New Flexibility Consolidation Sustainable in Jena by property Reunification Businesses profitable growth Carl Zeiß The Zeiss plant in Acquisi

  41. Slide 41: The Executive Board

    The Executive Board Jenoptik Investor Relations Presentation 41

  42. Slide 42: The Supervisory Board (as of April 30, 2026)

    The Supervisory Board (as of April 30, 2026) Daniela Mattheus, Chairwoman of the Supervisory Board Jakob Habermann*, Deputy Chairman of the Supervisory Board Professional Supervisory Board member and management Trade union secretary of the IG Metall central district management, consultant, Berlin, G

  43. Slide 43: Overview of quarters 2024 and 2025

    Overview of quarters 2024 and 2025 In million euros Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Q2/2025 Q3/2025 Q4/2025 2025 Revenue 256.1 284.7 274.3 300.7 1,115.8 243.6 254.8 254.8 292.8 1,046.0 EBITDA 44.5 56.9 59.1 61.0 221.5 36.2 42.6 53.0 60.7 192.5 EBITDA margin in % 17.4 20.0 21.6 20.3 19.9

  44. Slide 44: Revenue increase in the Americas

    Revenue increase in the Americas Revenue by region 2025 Revenue by region in million euros 2024 Europe 5% 309.8 −7.1% (without 24% Germany) 333.4 17% 254.5 Germany −20.1% 318.3 253.7 Americas +4.1% 243.8 24% 175.7 30% Asia / Pacific −4.1% 183.2 Middle East / 52,3 Africa +40.8% 37.1 Middle East / Afr

  45. Slide 45: Key figures – five-year overview

    Key figures – five-year overview In million euros 2025 2024 2023 2022* 2021* Revenue 1,046.0 1,115.8 1,066.0 980.7 750.7 155.7 (incl. one-offs) EBITDA 192.5 221.5 209.6 184.1 125.2 (excl. one-offs) 20.7 (incl. one-offs) EBITDA margin (in %) 18.4 19.9 19.7 18.8 16.7 (excl. one-offs) EBIT 114.5 146.6

  46. Slide 46: Strong R+D commitment; continuing expansion of sales structures abroad

    Strong R+D commitment enables fundamentally new products; continuing expansion of sales structures abroad R+D output Selling expenses Administrative expenses in million euros in percent in million euros in percent in million euros in percent 120 10.6 12,0 120 11.9 100 10 9.5 11.0 9.9 9.7 9.3 12 8.5

  47. Slide 47: Key figures by segment 2025

    Key figures by segment 2025 Semiconductor & Metrology & Advanced Production Smart Mobility in million euros Manufacturing Biophotonics Solutions Solutions Group2) Revenue1) 434.4 245.4 206.7 129.7 1,046.0 EBITDA 114.2 52.2 16.1 17.7 192.5 EBITDA margin in % 25.7 21.1 7.8 13.6 18.4 Order intake1) 404

  48. Slide 48: Quarterly key figures by segment 2025

    Quarterly key figures by segment 2025 Semiconductor & Advanced Manufacturing Biophotonics in million euros Q1 Q2 Q3 Q4 in million euros Q1 Q2 Q3 Q4 Revenue1) 100.9 108.2 105.8 119.5 Revenue1) 63.8 55.5 62.9 63.3 EBITDA 21.4 26.6 30.3 36.0 EBITDA 15.6 9.8 13.7 13.1 EBITDA margin in % 20.5 23.9 27.8 2

  49. Slide 49: Quarterly key figures by segment 2025

    Quarterly key figures by segment 2025 Metrology & Production Solutions Smart Mobility Solutions in million euros Q1 Q2 Q3 Q4 in million euros Q1 Q2 Q3 Q4 Revenue1) 40.6 51.4 47.0 67.7 Revenue1) 28.7 33.0 32.7 35.3 EBITDA –3.4 3.5 1.7 14.3 EBITDA 1.9 3.9 5.6 6.3 EBITDA margin in % –8.3 6.7 3.7 21.1 E

  50. Slide 50: Acquisitions and divestments over last years

    Acquisitions and divestments over last years Non-organic growth initiatives (M&A) Key acquisition criteria Divestments Hillos VINCORION − Portfolio: Complementary technologies & Non-optical process metrology regional expansion Crystal growth business − Market position: strong technological basis, 20

  51. Slide 51: Shareholders and dividend information

    Shareholders and dividend information Shareholder structure Thüringer Dividend Industriebeteiligungs EPS Dividend payment 11.0% GmbH & Co. KG 2,0 1.62 1,6 1.43 1.27 1.26 1,2 0.96 89.0% 0,8 0.30 0.35 0.38 0.40e Freefloat 0,4 0.25 0,0 2021 2022 2023 2024 2025 Major institutional shareholders (20.03.20

  52. Slide 52: Dates and contact

    Dates and contact 12.05.2026 Publication Q1/2026 13.05.2026 UBS Conference, London 19.05.2026 Berenberg European Conference, New York 21.05.2026 Bernstein Conference, Nice 09.06.2026 Annual General Meeting 2026 16.-17.06.2026 Roadshow Benelux / Paris Andreas Theisen Sabine Barnekow https://www.jenop

Jenoptik — Investor Presentation (May 2026) on 6ix